HCA Healthcare reported third quarter 2026 results that exceeded analyst expectations for both revenue and earnings, driven by resilient patient volumes. Despite a significant headwind from a payer mix shift toward uninsured patients following health insurance exchange attrition, strong growth in emergency room visits and equivalent admissions supported narrowed full-year guidance toward the upper end of prior ranges.
Key Highlights
- Same-facility equivalent admissions increased 3.0% YoY, outperforming analyst estimates of 1.7% growth.
- The company absorbed a $400 million headwind to pre-tax income caused by patients losing coverage on health insurance exchanges.
- Same-facility emergency room visits rose 5.1%, offsetting a 1.4% decline in inpatient surgeries and a 3.7% decline in outpatient surgeries.
- HCA returned $2.97 billion to shareholders through share repurchases in the quarter and declared a $0.78 per share quarterly dividend.